Westover Capital Advisors, LLC Halozyme Therapeutics, Inc. Transaction History

Westover Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 22, 2023	SELL	$32.86 - $55.7 $6,572 - $11,140	-200 Reduced 1.5%	13,164 $502,000
Q4 2022 May 18, 2023	BUY	$40.06 - $59.44 $535,361 - $794,356	13,364 New	13,364 $760,000
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $239,206 - $288,639	-6,218 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$38.84 - $51.31 $241,507 - $319,045	6,218 New	6,218 $282,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Westover Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Westover Capital Advisors, LLC with notifications on news.